Drexel University, Philadelphia
Findings in cardiovascular disease provide new insights
Published in Disease Risk Factor Week, April 30th, 2006
Study 1: Chronic antithrombotic therapy in post-myocardial infarction patients is reviewed in a recent issue of Clinics in Geriatric Medicine.
According to the review from the United States, "Recent advances in the acute treatment of myocardial infarction (MI) have allowed more to survive the initial event in coronary artery disease. Increasing importance has been placed on secondary-prevention strategies, with more attention directed toward an optimal therapeutic regimen for post-MI patients."
"When it comes to the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Disease Risk Factor Week
More Articles from Disease Risk Factor Week
- American Medical Association
Prevalence of overweight children, teens and men in U.S. continues to rise - Hamilton Health Sciences Corporation
Studies advance knowledge in diet & nutrition research - Abbott Laboratories
Paclitaxel efficacy enhanced by novel compound 73R - Acusphere
Acusphere adds Mona Haynes as vice president, marketing and sales - Addiction Medicine
Dr. Raymond Johnson presents preliminary outcomes data on PROMETA addiction treatment - Advocacy
Healthcare workers must be given a fairer deal, says WHO - More from this issue of Disease Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
